1. Cytostatic drugs in infants: A review on pharmacokinetic data in infants
   Hendrik van den Berg et al, 2012, Cancer Treatment Reviews CrossRef
2. The Epigenetics of Brain Tumors
   Adrian M. Dubuc et al, 2012, Cancer Epigenetics CrossRef
3. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial
   G. Cefalo et al, 2014, Neuro-Oncology CrossRef
4. Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y
   Ayhan Bilir et al, 2010, Journal of Neuro-Oncology CrossRef
5. Temozolomide and Other Potential Agents for the Treatment of Glioblastoma Multiforme
   Daniel T. Nagasawa et al, 2012, Neurosurgery Clinics of North America CrossRef
6. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors
   Lu‐Ting Kuo et al, 2016, Cancer Medicine CrossRef
7. Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours
   A O von Bueren et al, 2012, British Journal of Cancer CrossRef
8. Transforming approaches to treating TRK fusion cancer: historical comparison of larotrectinib and histology-specific therapies
   Megan Pollack et al, 2021, Current Medical Research and Opinion CrossRef
9. Epigenetics and Brain Cancer
   Davide Sciuscio et al, 2013, Emerging Concepts in Neuro-Oncology CrossRef
10. The Transcription Factor Evi-1 Is Overexpressed, Promotes Proliferation, and Is Prognostically Unfavorable in Infratentorial Ependymomas
    Björn Koos et al, 2011, Clinical Cancer Research CrossRef
11. Aberrant Methylation of Different DNA Repair Genes Demonstrates Distinct Prognostic Value for Esophageal Cancer
    Zhi-Qiang Ling et al, 2011, Digestive Diseases and Sciences CrossRef